Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrapleural Fibrinolysis and DNase Versus VATS for the Treatment of Pleural Empyema: a Randomized, Controlled Trial

NCT04095676 is registered in ClinicalTrials.gov with Thomas Decker Christensen as lead sponsor.

NCT NCT04095676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04095676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrapleural Fibrinolysis and DNase Versus VATS for the Treatment of Pleural Empyema: a Randomized, Controlled Trial
Lead sponsor
Thomas Decker Christensen
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2022
Completion date
October 30, 2028
Enrollment
184 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pleural empyema